ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

Chabner Criticizes FDA Crackdown On Off-Label Info

June 28, 1991

Gene Therapy Appears to Benefit Two Children With ADA Deficiency, Scientist Tells Writers

April 9, 1993

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

June 24, 2011